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Alzheimer’s diseasea b s t r a c t
Interaction of b-amyloid peptide (Ab) with cell membranes is thought to be an initial step in
Alzheimer’s disease (AD). However, some data are controversial and the underlying mechanisms
remain unclear. In this report, two populations of Ab were found in human SK-N-SH neuroblastoma
cells. Notably, one of the Ab populations was tightly inserted into the plasma membrane whilst the
other was only peripherally associated with it. Here we show that reducing membrane cholesterol
decreased the number of membrane-embedded Abs and increased the number of
membrane-attached Abs. We also found that cholesterol depletion inhibited Ab degradation and
exacerbated Ab-mediated cytotoxicity. Our detailed and direct observations provide speciﬁc insights
into the mechanism of Ab membrane-associated toxicity.
 2015 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
Alzheimer’s disease (AD) is the most common age-related neu-
rodegenerative disorder characterized by the loss of neurons,
extracellular senile plaques, and intracellular neuroﬁbrillary tan-
gles [1,2]. The core component of the plaques is b-amyloid peptide
(Ab), which is known to assemble to form ‘toxic’ oligomers that
may be crucial in initiating AD pathology [3,4]. Ab is generated
after sequential cleavage of the amyloid precursor protein (APP)
within the transmembrane domain, thus the cleaved peptides
retain some membrane perforating properties.
It has been shown that the amphiphilic Ab can speciﬁcally bind
to phospholipid bilayers with relatively high afﬁnity, suggesting
that the cell membrane of neurons may be a primary target of Ab
[5,6]. Various biomimetic membrane models (e.g. lipid monolay-
ers, bilayers and liposomes) have been used to examine the inter-
actions between Ab and membrane surfaces, as well as the
resulting disruption [4]. Ab has been reported to form ionic pores,
directly leading to cell death or triggering the apoptotic signalingthrough interference with the regulation of calcium homeostasis
[7]. Ab can also alter the physicochemical properties of neuronal
membranes (e.g. membrane ﬂuidity), and induce membrane desta-
bilization and permeabilization [8]. Both membrane-Ab interac-
tions and toxicity seem to be modulated by the lipid
composition, particularly cholesterol and ganglioside, which are
speculated to be the major components in the lipid-raft domains
of the plasma membrane. It has been reported that cholesterol
enhances the binding of Ab to a lipid bilayer and facilitates Ab
aggregation [9]. Cholesterol depletion can reduce the formation
of insoluble Ab in hippocampal neurons [10]. However, Ji et al. con-
sider cholesterol an important factor affecting the membrane
insertion of Ab40, which may potentially inhibit ﬁbril formation
[11]. Other reports have also shown that membrane cholesterol
has a protective action by suppressing amyloid toxicity [12–14].
Thus, the role of cholesterol in AD remains controversial.
Inconsistent data and conclusions reported in the literature make
it difﬁcult to determine the exact mechanism underlying the
membrane-associated toxicity of Ab. The lack of a clear and
detailed description of Ab-membrane interactions hinders a com-
plete understanding of Ab toxicity in AD pathogenesis.
Notably, previous in vitro physicochemical studies were mainly
performed with artiﬁcial membranes utilizing biophysical tech-
niques. These simulative data might not faithfully reﬂect the
pathophysiological situation of in vivo Ab-membrane interactions
and therefore may not expose any of the causes of conﬂicting
results. In addition, the exact locations of the peptides present
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membrane isolated from neuronal cells to investigate the
Ab-membrane interactions in detail. Furthermore, a sequential
extraction method allowed differential Ab isolation, enabling the
exact location of membrane Ab to be uncovered. This work pro-
vides molecular-level information of Ab-membrane interactions
and their modulation by cholesterol, offering hints into the pathol-
ogy of AD.
2. Materials and methods
2.1. Ab peptides, antibodies and reagents
Lyophilized Ab (Bachem Americas, Inc.) was dissolved in
dimethyl sulfoxide, sonicated for 30 s in a bath sonicator at 4 C,
and centrifuged (15000g  10 min) to remove insoluble particu-
lates [15]. The peptide concentration was determined using the
BCA protein assay. Monoclonal antibody 6E10, which recognizes
an epitope within residues 1–17 of human Ab, was purchased from
Millipore Corporation. Actin and ﬂotillin antibodies are from Santa
Cruz Biotechnology Inc. Secondary antibodies were obtained from
ZhongShan Biotechnology Inc. Methyl-b-cyclodextrin (MbCD),
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT), ultra-low range molecular weight marker were purchased
from Sigma Chemical Co. Dulbecco’s modiﬁed Eagles’ medium
(DMEM), fetal bovine serum (FBS), glutamine, penicillin, strepto-
mycin, Amplex Red Cholesterol Assay Kit, BCA protein assay kit
were obtained from Thermo Fisher Scientiﬁc. Protease inhibitor
cocktail was product of Roche.
2.2. Cell culture
Human SK-N-SH neuroblastoma cells were cultured in DMEM
medium supplemented with 10% FBS, 1 mM glutamine, and
100 unit/ml penicillin and 100 mg/ml streptomycin. Cell cultures
were maintained in a 5% CO2, humidiﬁed atmosphere at 37 C
and grown until 80% conﬂuent for a maximum of 20 passages.
2.3. Preparation and characterization of plasma membranes
Membrane preparation was performed as described previously
with minor modiﬁcations [16]. Brieﬂy, cells were washed twice
with PBS, and harvested by scraping with a rubber policeman.
Hereinafter all manipulations were carried out at 4 C using
pre-cooled reagents. Collected cells were resuspended at
1  108/ml in homogenization buffer (HB; 0.25 M sucrose/10 mM
HEPES/1 mM EDTA, pH 7.4) supplemented with protease inhibitor
cocktail and then homogenized using a Dounce glass-Teﬂon
homogenizer. Homogenates were centrifuged at 800g for 10 min
to pellet nuclei and unbroken cells, which were then rehomoge-
nized. Supernatant was combined and centrifuged at 3000g for
10 min to remove large heavy mitochondria. The resulting super-
natant was centrifuged at 100000g for 1 h to obtain crude mem-
brane and cytosol fractions. For purifying plasma membrane, the
supernatant (1 ml) was layered on 6 ml of iso-osmotic (0.25 M
sucrose) 30% Percoll (Pharmacia, Sweden) with a 1 ml cushion of
2.5 M sucrose at the bottom. After centrifuging at 27000g for
30 min in a ﬁxed-angle rotor (Hitachi P70AT2), fractions of 1 ml
were carefully collected from the top. Percoll was removed and
marker enzymes were assayed.
2.4. Cholesterol depletion
Cholesterol was depleted by incubating cells or isolated plasma
membranes with MbCD at 37 C in serum free medium or in PBS.The cholesterol content was assayed using the Amplex Red
Cholesterol Assay Kit [17,18].
2.5. Sequential extraction of membrane proteins
Isolated plasma membranes were incubated in 0.1 M Na2CO3
(pH 11.0) for 30 min and ultracentrifuged (30 min at 100000g) to
give peripheral membrane proteins. The pellet of
carbonate-washed membranes was further striped by incubation
with 1 M NaCl for 30 min and spun as above. The ﬁnal membrane
pellet containing membrane-integrated Ab was solubilized in 2%
SDS. All the buffers were supplemented with protease inhibitor
cocktail and all the procedures were conducted at 0–4 C [19].
As Ab was incubated in vitro with biological membranes, iso-
lated SK-N-SH plasma membranes containing 100 lg protein were
cholesterol modulated with 10 mM MbCD for 15 min or left
untreated, and then ultracentrifuged for 30 min at 100000g to
remove MbCD. These pelleted membranes were resuspended in
100 ll HEPES buffer (0.05 M, pH 7.4) containing protease inhibitor
cocktail. Freshly dissolved Ab peptides (0.1 lM) were added and
incubated at 37 C for 2 h. After incubation, the samples were frac-
tionated as above to obtain free, membrane-attached and
membrane-inserted proteins.
2.6. Immunoblotting
Methods for SDS–Tricine–PAGE and Western blotting were per-
formed as described previously [20].
2.7. Measurement of cell viability
Cell viability assays were carried out by MTT dye conversion
assay [21] in 96-well cell culture plates. SK-N-SH cells, with or
without the cholesterol content modulated as described above,
were exposed to 10 lM Ab for 48 h. All cells were then incubated
with a 0.5 mg/ml MTT solution at 37 C for 4 h and then with cell
lysis buffer (20% SDS, 50% N,N-dimethylformamide, pH 4.7) for
3 h. The absorbance values were determined at 590 nm. Cell viabil-
ity was expressed as a percent of OD of vehicle treated control, the
value of which was deﬁned as 100%. Assays were repeated in three
independent experiments, each performed in triplicate.
2.8. Data analysis
All data was expressed as mean ± standard deviation (S.D.).
Comparisons between different groups were performed by
ANOVA followed by the t-test, and P < 0.05 was considered statis-
tically signiﬁcant.
3. Results
3.1. Binding of Ab to biological plasma membrane
Previous in vitro biophysical works have implicated an impor-
tant role of Ab-membrane interactions in AD pathology [22–24].
To investigate whether Ab40, the major species normally secreted
from cells, could integrate into biological plasma membrane
in vivo, we incubated SK-N-SH cells with 10 lM of freshly dis-
solved Ab40 for 6 h at 37 C. After incubation, cells were fraction-
ated and the cytosol and crude membrane fractions were
analyzed by Western blotting to examine the presence of Ab.
Fig. 1A shows that cell-associated Ab is mainly distributed in the
membrane fraction. In addition, cells were double immunostained
with 6E10 and anti-ﬂotillin (a plasma membrane marker) antibod-
ies and this labeling displayed a co-localization of Ab with
Fig. 1. Ab is associated with plasma membranes. SK-N-SH cells were incubated
with 10 lM of freshly dissolved Ab for 6 h in binding media, and then plasma
membranes were isolated. (A) Ab existed in the plasma membranes (Flotillin as a
membrane marker; Actin as a cytosol marker). (B) Membrane-associated Ab could
be partially stripped by carbonate.
Fig. 2. Western blotting showing the modulating effect of cholesterol on Ab-
membrane interaction. SK-N-SH cells were pretreated with (+) or without ()
10 mMMbCD for 15 min, incubated with 10 lM Ab40 at 37 C for 6 h, and then
plasma membranes were isolated. (A) The extent of cholesterol depletion by MbCD
in SK-N-SH cells. (B) Analysis of equal amounts of membrane (mem) and cell media.
(C) Sequential extraction of Ab40 from membranes. Free, Ab in media; Na2CO3,
0.1 M carbonate extracted fraction; NaCl, 1 M NaCl extracted fraction; mem ins,
membrane-inserted protein fraction; Std, standard fresh Ab. (D) Cholesterol
depletion of SK-N-SH cells inhibits Ab degradation. After incubations of cells with
drugs, the levels of Ab in cell growth media was examined with Western blotting.
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shown). These observations indicated that Ab interacts with
plasma membrane.
Whether the membrane-associated Ab is tightly inserted into
the membrane remains unknown. To determine the exact state of
Ab on plasma membrane, we sequentially extracted the membrane
fraction with carbonate and high concentrations of sodium
chloride, which are widely used to strip peripherally
membrane-attached proteins [19]. After these treatments, the
proteins remaining in the membrane fraction are considered to be
tightly inserted into the membrane. Thus, membrane-associated
proteins are fractionated into ‘‘membrane-attached’’ (Na2CO3-
and NaCl-extractable), and ‘‘membrane-inserted’’ (detergent-
extractable) pools. The distribution of membrane-associated Ab40
is shown in Fig. 1B. A portion of themembrane Ab40 can be stripped
by 0.1 M Na2CO3, while another portion is retained in the biomem-
brane after the washing with 0.1 M Na2CO3 and 1 M NaCl solution.
As a control, intrinsic ﬂotillin has not been stripped from the mem-
brane by these polar reagents (Fig. 1B). This result suggests the
presence of two different forms of Ab in the plasmamembrane after
external Ab is incubated with the cells.
3.2. Effect of cholesterol depletion on the Ab-membrane interaction
Many studies have suggested a link between cholesterol and Ab
in Ab-mediated toxicity [4,8,25,26]. To determine the possible
effect of cholesterol on the membrane distribution and aggregation
of Ab, the plasma membrane cholesterol was decreased by MbCD.
MbCD is known to speciﬁcally remove cholesterol from the surface
of cultured cells [27]. First, we performed preliminary experiments
to determine the limit conditions for safe use of MbCD on our
SK-N-SH cells. Finally, treatment of SK-N-SH cells with MbCD
was set at 10 mMMbCD and 15 min duration. Under these condi-
tions, membrane cholesterol levels in the SK-N-SH cells were
reduced to approximately 60–70% of control without any apparent
inﬂuence on cell viability (Fig 2A).
In living cells, reducing cholesterol by MbCD could increase the
levels of membrane-associated Ab as well as those of free Ab in cell
media (Fig. 2B), supporting the involvement of cholesterol in
Ab-membrane interactions. The numbers of membrane-attached
and soluble proteins both showed an increase in the MbCD-treated
cells (Fig. 2C). Concomitantly, we assessed whether the membrane
cholesterol level can affect the degradation of Ab. As shown in
Fig. 2D, Ab levels in the cell media of the MbCD treatment group
was increased, suggesting that cholesterol depletion byMbCD could
prevent Ab degradation and this prevention would lead to an
increase in the concentration of Ab interacting with the membrane.
Taken together, cholesterol might inﬂuence the Ab-membrane
interactions through direct or indirect mechanism or both.To further elucidate the molecular basis of Ab-membrane inter-
actions and evaluate the role of cholesterol in modulating these
interactions, we incubated Ab40 monomers with puriﬁed plasma
membrane for 2 h in HEPES buffer (0.05 M, pH 7.4) in vitro.
Membranes were treated with MbCD to deplete cholesterol in
advance, or left untreated. Fig. 3A shows the membrane interac-
tions with Ab40 monomers. The levels of Ab40 attached to mem-
branes increased at a lower cholesterol levels (i.e. with MbCD
treatment), while there was also an apparent decrease of inserted
Ab aggregates of mid-molecular-weight in membrane fractions
from the MbCD treatment group (Fig. 3A). These data indicate that
cholesterol can have a signiﬁcant effect on the distribution of Ab40.
Additionally and interestingly, high-molecular-weight Ab oligo-
mers appeared to be distributed in the membrane-inserted fraction
(Figs. 2C, 3A), suggesting a role of membrane insertion in Ab
assembling. To determine whether the hydrophobic C-terminal
residues are required for Ab40 to penetrate into the membrane,
synthetic Ab28 (the isoform without C-terminal transmembrane
domain) were incubated with cells. Evidently, Ab28 existed only
in a free form without any association with membrane (Fig. 3B),
indicating that it was unable to insert into the plasma membrane.
3.3. Effects of cholesterol depletion on Ab toxicity
The results of Ab-membrane interactions showed that choles-
terol depletion inhibited Ab degradation, inﬂuenced Ab distribu-
tion in membrane fractions and increased Ab aggregation. To test
whether cholesterol might affect Ab-mediated cytotoxicity, a
MTT assay was applied to determine the cell viability after the
incubation period in the presence of the drugs. After the depletion
of cholesterol by MbCD, SK-N-SH cells were incubated with 10 lM
Ab. As shown in Fig. 4, Ab alone reduced the proportion of viable
cells to about 76%. Pretreatment with 10 mMMbCD for 15 min
enhanced the sensitivity of the cells to Ab without signiﬁcantly
affecting the baseline viability of the cells. Ab addition markedly
reduced the percentage of viable cells pretreated with MbCD to
Fig. 3. In vitro incubation of Ab with isolated plasma membranes. Samples
containing 100 lg of protein of isolated SK-N-SH cell membrane were resuspended
in 100 ll HEPES buffer supplemented with (+) or without () MbCD at 37 C. After
30 min suspension was centrifuged at 100000g for 30 min to remove MbCD. Pellet
was resuspended and freshly dissolved Ab peptides (0.1 lM, monomer) were then
added and incubated at 37 C for 2 h. After incubation, the samples were
fractionated into free Ab (free), 0.1 M carbonate extract (Na2CO3), 1 M NaCl extract
(NaCl), and membrane-inserted fraction (insertion) as described in the Materials
and methods. (A) Subfractionation of Ab40-membrane mixtures. (B)
Subfractionation of Ab28-membrane mixtures.
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results suggest that cholesterol depletion exacerbates Ab-induced
cell toxicity.
4. Discussion
In this study, we performed a sequential extraction experiment
to fractionate the Ab-membranes mixture to determine the exact
location of Ab in the plasma membrane. Two populations were
found for membrane Ab40: a membrane-attached state, looselyFig. 4. MbCD aggravates Ab40-mediated cytotoxicity. Cytotoxicity was determined
by a MTT assay as described in the Materials and methods. SK-N-SH cells were
preincubated with 10 mM MbCD for 15 min. MbCD was withdrawn and Ab was
added. The cells were then incubated for 48 h, and the assays performed. Values are
the means ± S.D. (*P < 0.05). Ctrl, control.adsorbed onto the cell membrane surface that could be detached
by carbonate, and a membrane-inserted state, tightly associated
with the membrane, which could not be extracted by polar
reagents (solutions with an elevated pH and high salt concentra-
tion). Moreover, high-molecular-weight oligomers tended to insert
into the membrane, while monomer and low-molecular-weight
species were mainly loosely attached to it. Our biochemical data
provides direct insight into the nature and the molecular details
of Ab-membrane interactions, suggesting two types of interaction
of Ab with membrane, consistent with a previous report [28] and
a study for Ab25-35 [29].
In general, it is believed that integral proteins extend across or
are partially inserted into the lipid bilayers through interactions
with hydrophobic moieties. We found that Ab28, the isoform with-
out C-terminal transmembrane domain was not able to intercalate
into the membrane at all, suggesting that Ab40 may insert into the
membrane via C-terminus hydrophobic interactions. For periph-
eral Ab, a membrane surface attachment via electrostatic interac-
tions is supported by the evidence here, since dissociation could
be induced by treatment with alkaline buffers or salts. Thus, the
two types of Ab-membrane interactions may bring about the two
populations of Ab in the membrane. Conditions inﬂuencing the
hydrophobic exposure of Ab may affect the membrane insertion
and aggregation of Ab.
Cholesterol is known to be the predominant sterol in the plasma
membrane, required for normal synaptic function and cell plastic-
ity as well as a major risk factor for AD development [25,30].
Mounting evidence point out that cholesterol plays a pivotal role
in the interactions between Ab and neuronal membranes.
However, data reported in the literature shows discrepancies pos-
sibly because of the complex nature of membranes or the different
experimental conditions used [9,10,12,14,31,32]. In vitro and
in vivo regulation of membrane cholesterol levels affect different
cholesterol pools within the plasma membrane bilayer and these
pools are differentially sensitive to Ab’s disrupting effects. The pre-
sent study now provides evidence that cholesterol modulates the
distribution of Ab40 peptide on the plasma membrane (Fig. 3).
Furthermore, cholesterol depletion can inhibit the degradation of
Ab (Fig. 2D). These observations coincided with an accentuation
in the toxic effects of Ab from a reduction in cholesterol (Fig. 4),
which might be a result of an incremental increase in membrane
Ab. It has been reported that in AD brains, the cholesterol/phos-
pholipid ratio is reduced by as much as 30% whereas the phospho-
lipid/protein ratio remains unchanged [33]. In another study
examining the effect of Ab on lipid metabolism, we had found that
Ab40 oligomers promoted membrane cholesterol efﬂux and
decreased cell cholesterol content (data not shown), which is in
agreement with the literature [34]. Therefore, we speculate that
the consequences of the interaction between cholesterol and Ab
may be bidirectional: cholesterol reduction increases the adsorp-
tion of Ab to membranes and facilitates Ab oligomerization, which
in turn disturb the structure and composition of the membranes,
such as cholesterol efﬂux and membrane ﬂuidity, leading to a fur-
ther decrease of cholesterol content of the cell membrane. On the
other hand, cholesterol induces an increased membrane-inserted
Ab to assemble into a pore/channel which causes toxic effect
through calcium dyshomeostasis [35]. It also reduces
membrane-attached Ab, the primarily small oligomers which are
known to be the most toxic species [3]. Thus, cholesterol has dual
effects on the membrane Ab and plays a role on Ab degradation,
which may render cells less vulnerable to amyloid cytotoxicity.
Some previous studies have reported that cholesterol promotes
the interaction of Ab with lipid bilayers or facilitates the formation
of ion channels [9,35,36]. It seems like opposite to the results of
present study. However, these works pointed out that cholesterol
may greatly interact directly with Ab and assist it inserting into
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numbers of membrane-embedded proteins and increased
membrane-attached proteins. Therefore, we considered that they
are not conﬂicting in fact. On the contrast, it can be claimed that
they are consistent in inﬂuencing Ab insertion into membrane.
Two pools of Ab existing in the membranes should be taken into
account when studying the role of cholesterol in Ab-membrane
interactions. The modulation effect of cholesterol on the levels of
each pool is actually different.
Of note, a pool of large molecular aggregates of Ab in the inte-
gral membrane protein fraction was observed, which may have
particular relevance for the development of AD, as increased accu-
mulation can occur with time and this eventually manifest as
deposits in the brain [37]. The conversion of soluble monomeric
Ab into insoluble aggregates is critical for the disease process,
but remains to be clariﬁed. This study may suggest an origin for
the large assemblies integrated in the plasma membranes. From
the in vitro immunoblotting results (Fig. 3), monomers and small
oligomers of Ab were able to insert into the membrane, although
the amount was low. The similarities of the oligomerization degree
between soluble and membrane-attached Ab indicate that Ab may
initially aggregate in the medium and then bind to or be inserted
into the cell membranes. Small membrane-inserted Ab oligomers
can further assemble into insoluble aggregates. This observation
is in accordance with the ion channel hypothesis for AD [38]. In
the present study, we did not distinguish which population of Ab
contributes more to the Ab-mediated membrane toxicity, but oli-
gomer species are currently thought to be more toxic than amyloid
ﬁbers [3]. This is important for understanding AD pathogenesis and
needs further careful investigation.
In conclusion, here we demonstrate that Ab40 can interact with
cell plasma membranes and two Ab-membrane states are appar-
ent: a membrane-attached state and a membrane-inserted state.
Membrane-inserted Ab tends to form large aggregates. The distri-
bution of the Ab within the plasma membrane as well as the
Ab-induced toxicity on SK-N-SH cells can be modulated by
the amount of cholesterol in the membranes. The presence of the
two pools of Ab in cell membranes may inﬂuence our knowledge
of the mechanism of Ab neurotoxicity and data interpretation.
Overall, our ﬁndings may provide an explanation for the accelera-
tion of Ab aggregation and membrane insertion, affording further
insights into the molecular mechanism of the amyloid toxicity.
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